Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.
The anti-CD20 chimeric antigen receptor (CAR) THP1 cell line is a stable cell line developed using anti-CD20 CAR lentivirus transfection. This transfected CAR lentiviral vector is constructed to express a scfv of anti-CD20 antibody (Rituximab) linked to CD147 signaling domains.The anti-CD20 CAR engineered THP1 cells can be used to be differentiated into macrophage cells for in vitro or in vivo phagocytosis studies. This CAR-THP1 cell line product can be used for the researches of Lymphoma.
Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.